down arrow

Retractable Technologies, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US76129W1053
USD
0.81
-0.01 (-0.86%)

Dec 04

ASE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.810.82

52 Week

0.591.14
Valuation
Technical
Day's Volume

CASH

2.55 k

Shareholding (Mar 2025)

FII

0.22%

Held by 6 FIIs

DII

96.26%

Held by 4 DIIs

Promoter

0.00%

How big is Retractable Technologies, Inc.?

22-Jun-2025

As of Jun 18, Retractable Technologies, Inc. has a market capitalization of 19.56 million and reported net sales of 33.75 million with a net profit of -22.81 million over the latest four quarters. Shareholder's funds are 87.17 million, and total assets amount to 160.72 million.

As of Jun 18, Retractable Technologies, Inc. has a market capitalization of 19.56 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 33.75 million, while the sum of net profit for the same period is -22.81 million.<BR><BR>As of Dec 24, the shareholder's funds are reported at 87.17 million, and total assets amount to 160.72 million.

Read More

What does Retractable Technologies, Inc. do?

22-Jun-2025

Retractable Technologies, Inc. designs and manufactures safety medical products for the healthcare sector. As of March 2025, it reported net sales of $8 million and a net loss of $11 million, with a market cap of $19.56 million.

Overview:<BR>Retractable Technologies, Inc. designs, develops, and manufactures safety medical products for the healthcare industry, operating within the Pharmaceuticals & Biotechnology sector and categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 8 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -11 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 19.56 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.45 <BR>Return on Equity: -32.28% <BR>Price to Book: 0.26<BR><BR>Contact Details:<BR>Address: 511 Lobo Ln, LITTLE ELM TX: 75068-5295 <BR>Tel: 1 972 2941010 <BR>Fax: 1 972 2923600

Read More

Who are in the management team of Retractable Technologies, Inc.?

22-Jun-2025

As of March 2022, the management team of Retractable Technologies, Inc. includes Mr. Thomas Shaw as Chairman, President, and CEO, and Mr. John Fort as Vice President, CFO, Treasurer, and Director, along with several independent directors.

As of March 2022, the management team of Retractable Technologies, Inc. includes Mr. Thomas Shaw, who serves as the Chairman of the Board, President, and Chief Executive Officer. Mr. John Fort holds the positions of Vice President, Chief Financial Officer, Treasurer, and Director. Additionally, the board features several independent directors: Mr. Walter Bigby, Mr. Darren Findley, Mr. Marco Laterza, and Ms. Amy Mack. <BR><BR>In summary, the key members of the management team are Mr. Thomas Shaw and Mr. John Fort, along with a group of independent directors.

Read More

Is Retractable Technologies, Inc. overvalued or undervalued?

20-Sep-2025

As of May 15, 2023, Retractable Technologies, Inc. is considered overvalued and risky due to negative earnings and poor return metrics, with key ratios indicating underperformance compared to peers and a significant long-term decline in stock value.

As of 15 May 2023, the valuation grade for Retractable Technologies, Inc. has moved from expensive to risky, indicating a shift in perception regarding its financial health and market position. The company is considered overvalued given its negative earnings and poor return metrics. Key valuation ratios include a Price to Book Value of 0.26, an EV to EBIT of 0.64, and an EV to EBITDA of 0.96, all of which suggest that the company's valuation is not supported by its financial performance.<BR><BR>In comparison to its peers, Retractable Technologies, Inc. has a significantly lower EV to EBITDA ratio than Delcath Systems, Inc. at 60.33 and Neuronetics, Inc. at -7.61, highlighting its relative underperformance in the market. Additionally, while the company has shown a positive return of 20.35% year-to-date, it still lags behind the S&P 500's return of 12.22% during the same period, and its long-term performance has been notably poor with a 5-year return of -88.89% compared to the S&P 500's 96.61%.

Read More

Is Retractable Technologies, Inc. technically bullish or bearish?

20-Sep-2025

As of August 29, 2025, Retractable Technologies, Inc. shows a mildly bullish trend supported by positive MACD signals and moving averages, despite longer-term underperformance compared to the S&P 500.

As of 29 August 2025, the technical trend for Retractable Technologies, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, and the monthly MACD is mildly bullish, supporting the positive outlook. Daily moving averages are also bullish, while the weekly Bollinger Bands indicate a bullish stance, although the monthly Bollinger Bands are bearish. The KST shows a bullish signal on the weekly and mildly bullish on the monthly. <BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 2.16% and 3.51% compared to the S&P 500's 1.05% and 2.33%, respectively. However, the longer-term returns are concerning, with a 1-year return of -6.96% versus the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, driven primarily by the MACD and moving averages.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 24 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.42

stock-summary
Return on Equity

-20.78%

stock-summary
Price to Book

0.31

Revenue and Profits:
Net Sales:
10 Million
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.31%
0%
4.31%
6 Months
21.1%
0%
21.1%
1 Year
27.34%
0%
27.34%
2 Years
-28.03%
0%
-28.03%
3 Years
-60.05%
0%
-60.05%
4 Years
-89.09%
0%
-89.09%
5 Years
-91.85%
0%
-91.85%

Retractable Technologies, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Retractable Technologies, Inc. technically bullish or bearish?

As of 29 August 2025, the technical trend for Retractable Technologies, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, and the monthly MACD is mildly bullish, supporting the positive outlook. Daily moving averages are also bullish, while the weekly Bollinger Bands indicate a bullish stance, although the monthly Bollinger Bands are bearish. The KST shows a bullish signal on the weekly and mildly bullish on the monthly. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 2.16% and 3.51% compared to the S&P 500's 1.05% and 2.33%, respectively. However, the longer-term returns are concerning, with a 1-year return of -6.96% versus the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, driven primarily by the MACD and moving averages....

Read More

Is Retractable Technologies, Inc. overvalued or undervalued?

As of 15 May 2023, the valuation grade for Retractable Technologies, Inc. has moved from expensive to risky, indicating a shift in perception regarding its financial health and market position. The company is considered overvalued given its negative earnings and poor return metrics. Key valuation ratios include a Price to Book Value of 0.26, an EV to EBIT of 0.64, and an EV to EBITDA of 0.96, all of which suggest that the company's valuation is not supported by its financial performance. In comparison to its peers, Retractable Technologies, Inc. has a significantly lower EV to EBITDA ratio than Delcath Systems, Inc. at 60.33 and Neuronetics, Inc. at -7.61, highlighting its relative underperformance in the market. Additionally, while the company has shown a positive return of 20.35% year-to-date, it still lags behind the S&P 500's return of 12.22% during the same period, and its long-term performance has be...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.10%
EBIT Growth (5y)
-239.07%
EBIT to Interest (avg)
11.61
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0.45
Tax Ratio
60.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.74%
ROCE (avg)
57.80%
ROE (avg)
21.39%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.26
EV to EBIT
0.64
EV to EBITDA
0.96
EV to Capital Employed
-0.35
EV to Sales
-0.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-32.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 6 Schemes (3.52%)

Foreign Institutions

Held by 6 Foreign Institutions (0.22%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 25.30% vs -8.79% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 99.05% vs -376.32% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.40",
          "val2": "8.30",
          "chgp": "25.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.30",
          "val2": "-2.80",
          "chgp": "-17.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.50",
          "val2": "-7.20",
          "chgp": "148.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.10",
          "val2": "-10.50",
          "chgp": "99.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-491.20%",
          "val2": "-563.80%",
          "chgp": "7.26%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -24.31% vs -54.01% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -70.00% vs -237.25% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33.00",
          "val2": "43.60",
          "chgp": "-24.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-13.50",
          "val2": "-4.00",
          "chgp": "-237.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "10.80",
          "val2": "-10.50",
          "chgp": "202.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.90",
          "val2": "-7.00",
          "chgp": "-70.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-638.60%",
          "val2": "-263.50%",
          "chgp": "-37.51%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
10.40
8.30
25.30%
Operating Profit (PBDIT) excl Other Income
-3.30
-2.80
-17.86%
Interest
0.00
0.00
Exceptional Items
3.50
-7.20
148.61%
Consolidate Net Profit
-0.10
-10.50
99.05%
Operating Profit Margin (Excl OI)
-491.20%
-563.80%
7.26%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 25.30% vs -8.79% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 99.05% vs -376.32% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
33.00
43.60
-24.31%
Operating Profit (PBDIT) excl Other Income
-13.50
-4.00
-237.50%
Interest
0.10
0.20
-50.00%
Exceptional Items
10.80
-10.50
202.86%
Consolidate Net Profit
-11.90
-7.00
-70.00%
Operating Profit Margin (Excl OI)
-638.60%
-263.50%
-37.51%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -24.31% vs -54.01% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -70.00% vs -237.25% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Retractable Technologies, Inc. stock-summary
stock-summary
Retractable Technologies, Inc.
Pharmaceuticals & Biotechnology
Retractable Technologies, Inc. designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe. It also sells the VanishPoint intravenous catheter, the VanishPoint blood collection tube holder and the VanishPoint blood collection set. The PatientSafe syringe reduces the risk of bloodstream infections resulting from catheter hub contamination. Its PatientSafe products include 3mL, 5mL, 10mL, 20mL, 30mL and 60mL syringes, and the PatientSafe Luer cap. Its product designs include retractable needle syringe designs, retractable needle designs and retractable needle dental syringe designs.
Company Coordinates stock-summary
Company Details
511 Lobo Ln , LITTLE ELM TX : 75068-5295
stock-summary
Tel: 1 972 2941010
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."